Ying Huang, chief executive officer, Legend Biotech, discussed new data from the CARTIFAN-1 and CARTITUDE-2 studies.
Ying Huang
Advertisement
Articles by Ying Huang
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Ying Huang, chief executive officer, Legend Biotech, discussed new data from the CARTIFAN-1 and CARTITUDE-2 studies.
